Virtual Medicinal Product (VMP)
-
Hydralazine 20mg powder for solution for injection ampoules
Name Details
Current Name
Hydralazine 20mg powder for solution for injection ampoules
|
Start Date
26-05-2004
|
End Date
|
Previous Name
Hydralazine 20mg injection ampoules
|
Start Date
19-02-2003
|
End Date
25-05-2004
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1.0
- UDFS UOM
- ampoule
- Unit Dose UOM
- ampoule
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Intravenous
- Form
- Powder for solution for injection
- Ontology Form/Route
- solutioninjection.intravenous, solutioninfusion.intravenous
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
C02DB02
BNF |
Current BNF
02050100
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
02050100
|
Start Date
03-02-2005
|
End Date
03-04-2022
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
34193811000001100 |
13-03-2017 |
|
318651004 |
19-02-2003 |
12-03-2017 |
VMP Ingredients
Name
Hydralazine hydrochloride
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
20.0
Strength and UOM (Dmr)
Parent Products
-
VTM
Hydralazine
-
VMP
(Current) Hydralazine 20mg powder for solution...
Virtual Medicinal Product Pack (VMPP) Information